Skip to main content
Central European Journal of Urology logoLink to Central European Journal of Urology
. 2012 Sep 4;65(3):135–138. doi: 10.5173/ceju.2012.03.art7

Assessing the Influence of Benign Prostatic Hyperplasia (BPH) on Erectile Dysfunction (ED) among patients in Poland

Sławomir Dutkiewicz 1,2,, Dariusz Skawiński 1, Wiesław Duda 2, Magdalena Duda 2
PMCID: PMC3921801  PMID: 24578949

Abstract

Introduction

Erectile dysfunction (ED) and the lower urinary tract symptoms caused by benign prostatic hyperplasia (LUTS/BPH) are highly prevalent among aging men. More data are needed from studies evaluating the impact of LUTS/BPH on ED. This study aimed to assess ED in patients with LUTS/BPH independent of comorbidities.

Material and methods

During 2007 and 2008, we examined 10,932 patients aged 50 to 69 years with LUTS/BPH (IPSS = 8-19 points) using questionnaires: Sex-Score and International Index of Erectile Function 5 (IIEF-5). Patients who used alcohol and/or cigarettes and those with hypertension, diabetes, or hyperlipidemia and cholesterolemia were excluded from meta analyses, which left 4,354 patients with LUTS/BPH without any comorbidity for the analyses. The main survey instruments used were the Sex-Score and IIEF-5.

Results

Regarding sexual coexistence, 1,497 (34.4%) and 2,638 (60.6%) patients considered it very important or important respectively; however, 219(5%) patients reported no sexual activity. After excluding sexually inactive patients, only 1,088 (25%) patients had the ability to obtain an erection during sexual activity always or nearly always. However, that erection was only strong enough to penetrate their partner almost always or most of the time in 218 (5%) and 826 (19%) patients respectively and only 610 (14%) patients were always able to maintain their erection during sexual intercourse. While only 87 (2%) patients had no difficulty maintaining their erection until the completion of intercourse, 174 (4%) and 914 (21%) patients stated that sexual intercourse gave satisfaction nearly always or most of the time respectively.

Conclusions

The impact of ED on patients with LUTS/BPH is evident across domains.

Keywords: benign prostatic hyperplasia, erectile dysfunction, International Index of Erectile Function 5, International Prostate Symptom Score, lower urinary tract symptoms

INTRODUCTION

Lower urinary tract symptoms (LUTS) are recognized as a global term that encompasses all urinary symptoms, including storage, voiding, and post-micturition. In men, LUTS are often caused by benign prostatic hyperplasia (BPH) and are often attributed to histologic BPH, which also occurs more frequently with aging, with a reported prevalence in 50% of men aged 51-60 years, increasing to up to 90% of men aged 80 years or older. Erectile dysfunction (ED) is also common in older men aged over 50 years [1]. Independent of age, LUTS/BPH and ED are strongly linked with many comorbidities such as cardiovascular disease, diabetes, dyslipidemia, and obesity. A causal link between LUTS/BPH and ED has not yet been established [2, 3]. The prevalence of LUTS/BPH is known to increase with age [4].

This study sought out to assess ED in patients with LUTS/BPH independent of comorbidities.

MATERIALS AND METHODS

Our study retrospectively analyzed the patient data collected by general practitioners in Poland. During 2007 and 2008, 10,932 patients with a urological diagnosis of LUTS/BPH and an International Prostate Symptom Score (IPSS) from 8-19 points were examined and questioned in Polish by physicians. Patients were aged from 50-69 years and nearly half of them used alcohol and cigarettes. Comorbidities included hypertension (30%), diabetes (15%), and hyperlipidemia and cholesterolemia (nearly 5%). The comorbidities were treated at the discretion of the patient's physician. Treatments most commonly consisted of watchful waiting or herbal supplements and alfa-1 blockers. ED was not treated at this time. The preliminary results have been published previously [5].

Patients with an IPSS less than eight and greater than 19 were excluded from analyses in order to eliminate the extremes. Patients with comorbidities, as well as those who used alcohol and cigarettes, were also excluded from meta-analysis because these variables could also be factors leading to the development of ED and/or BPH. This left 4,354 patients to be included in the study. It should also be noted that these patients with LUTS/BPH were treated for less than six months and were without any chronic illness or reported ED. Outcomes were measured by assessing the results of questionnaires, the Sex-Score and International Index of Erectile Function (IIEF-5), as well as some additional inquiries regarding sexual activity and satisfaction. Sex-score assessed the ability to obtain an erection. The IIEF-5 was administered to assess the presence and severity of ED. The score is the sum of the responses to the five items so that overall score may range from 0 to 25. A score of 20 or higher indicates a normal degree of erectile function, while a score of 10 or less is indicative of moderate to severe ED. Descriptive statistics Chi-square values and Student-t tests were used (p <0.05 was considered significant).

RESULTS

We analyzed the results of 4,354 (100%) patients with LUTS/BPH on the basis of Sex-Score and IIEF-5 questionnaires. We found that sexual coexistence activity was at least important to 4,135(95%) patients, while the remaining 5% admitted to no sexual activity (Fig. 1). Sexually inactivity was observed in men who were of older age – most often because their wives had chronic illnesses that prevented sexual intercourse or they themselves resigned from a sexual lifestyle. Of the 95% that considered sexual coexistence important, only 1,088 (25%) patients were able to obtain an erection during sexual activity at least nearly always (Fig. 2). We also found that only 1,044 (24%) patients had an erection that was strong enough to penetrate their partner (Fig. 3) and only 610 (14%) were able to maintain their erection during sexual intercourse at least most of the time (Fig. 4); however, only 87 (2%) patients had no difficulty maintaining their erection until the completion of intercourse (Fig. 5). Contrary to the above results, 1,088 (25%) patients achieved satisfaction from sexual intercourse at least most of the time (Fig. 6).

Fig. 1.

Fig. 1

Rating the importance of sexual coexistence among the examined patients with BPH.

Fig. 2.

Fig. 2

Rating the importance of obtaining a full erection and ejaculation among the examined patients with BPH.

Fig. 3.

Fig. 3

Assessing the importance of obtaining a full erection and maintaining it among the examined patients with BPH.

Fig. 4.

Fig. 4

Assessing the ability to maintain erection until end of sexual intercourse among the examined patients with BPH.

Fig. 5.

Fig. 5

Assessing achievement of satisfaction from sexual intercourse among the examined patients with BPH.

Fig. 6.

Fig. 6

Results of the Sex-Score questionnaire the examined patients with BPH.

The final results of the IIEF-5 questionnaire revealed that a score of 21-25 points was achieved by only 174 (4%) patients (Fig. 7). The differences between the groups were found to be statistically significant (p <0.001-0.00001).

Fig. 7.

Fig. 7

Results of the IIEF-5 questionnaire among the examined patients with BPH.

We also found a full correlation between that an increase in IPSS (increased severity of BPH) was associated with more profound symptoms of ED.

DISCUSSION

The prevalence of LUTS/BPH and ED in men increases with age and both have been found to coexist in many men. This has increased the attention surrounding LUTS/BPH and ED and has urged us to delve into the relationship between them.

The Massachusetts Male Aging Study found that 52% of men aged 40-70 years had some degree of ED [6]. In Poland, 85% of similarly aged men examined for BPH also complained of ED [5]. These facts suggest that age might not be the only factor causing ED.

It was also found that age and BPH comorbidities influence the increased prevalence of men suffering from ED [7]. Even a mild increase in LUTS/BPH severity increased the incidence of ED and also strongly affected quality of life (QL) [8]. Hence, in our study we eliminated patients with BPH comorbidities and found that ED was present in 96% of patients with LUTS/BPH.

A multinational prospective study of sexual function and the comorbidities associated with LUTS/BPH found that hypertension (38%) and obesity (36%) were most commonly noted. It also found that 90% of men had moderate to severe LUTS, the severity of which increased with age, while sexual dysfunction was reported by 82% and directly correlated with the severity of LUTS. Of the 918 sexually active men in that study, only 20% had normal erectile function [9]. We found that only 4% of the 4,136 sexually active men in our study had normal erectile function. However, our study included only patients suffering from LUTS/BPH without the comorbidities that are known from many studies to affect erectile function [10].

Another study by Terai et al. [11] showed a significant association between LUTS/BPH and ED among Japanese men. Moreover, the Asian Survey of Aging Males (ASAM) was conducted using IPSS and IIEF-5 among others to determine the prevalence of LUTS/BPH and sexual disorders among men from five Asian countries aged 50-80 years. The results showed that sexual disorders increased with age and with increasing severity of LUTS/BPH and that sexual activity is common in Asian men, even at an advanced age. The ASAM study also confirmed the correlation between LUTS/BPH and ED [12].

In another study, Ponholzer and Madersbacher [13] stated that LUTS/BPH and ED are associated independently of age and major comorbidities.

Several supportive hypotheses regarding the association between LUTS/BPH and ED can be found in literature. For example, the autonomic hyperactivity present in hypertension has been suggested as a cause of LUTS/BPH and ED in aging men [14]. While other proposed causes of ED include decreased nitric oxide production in both the prostate and the smooth muscles of the penis, as well as the disorders of pelvic atherosclerosis and endothelial dysfunction. It was also found that the administration of sildenafil for ED improved LUTS/BPH [15] while significant improvements in erectile function were also observed after TURP [16].

Other published results determined that the quantitative growth of fibrous muscle tissue had a negative influence on the sexual activity of men suffering from BPH [17]. While subsequent studies determined a high correlation between ED and impaired micturition, especially urinary incontinence [18].

In our study, 25% of patients who suffered from LUTS/BPH stated that their sexual activity was satisfying nearly always (4%) or most of the time (21%). Similar results were published by Da Silva et al. [19].

ED has been classified as an essential dysfunctional element in the realms of sexuality and has a significant influence on QL [20]. While both LUTS/BPH and ED are known to significantly contribute to the patients overall QL.

Furthermore, it should be noted that the correlation between LUTS/BPH and ED might be partly due to cultural differences or geographical factors among others. It has also been postulated that ethnic differences as well as a social influence among Asian men may affect a patient's likelihood to report LUTS/BPH and sexual dysfunction. The American Cohort Study found that Asian men were less likely to seek medical or surgical intervention for LUTS/BPH [21, 22].

We believe that more multinational studies of men with LUTS/BPH and without chronic illness are necessary to confirm the correlation between LUTS/BPH and ED, and that these studies should assess urinary symptoms and erectile function using IPSS and IIEF respectively.

CONCLUSION

We found that 95% of patients from the studied group suffering from only LUTS/BPH considered their sexual relations as important in their lives. We also found that from among these patients only 25% were sexually satisfied and 61% were seldom satisfied, which may indicate a strong influence of LUTS/BPH on ED.

REFERENCES

  • 1.Rosen R, Altwein J, Boyle P, et al. Lower urinary tract symptoms and male sexual dysfunction: the Multinational Survey of the Aging Male (MSAM-7) Eur Urol. 2003;44:637–649. doi: 10.1016/j.eururo.2003.08.015. [DOI] [PubMed] [Google Scholar]
  • 2.McVary K. Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology. BJU Int. 2006;97(Suppl. 2):23–28. doi: 10.1111/j.1464-410X.2006.06102.x. [DOI] [PubMed] [Google Scholar]
  • 3.Melman A, Gindell JC. The epidemiology and pathophysiology of erectile dysfunction. J Urol. 2005;161(1):5–11. [PubMed] [Google Scholar]
  • 4.Naderi N, Mochtar CA, de la Rosette JJ. Real life practice in the management of benign prostatic hyperplasia. Curr Opin Urol. 2004;14(1):41–44. doi: 10.1097/00042307-200401000-00009. [DOI] [PubMed] [Google Scholar]
  • 5.Dutkiewicz S, Duda W, Duda M. Preliminary study the assessment of sexual function and erectile dysfunction patients with benign prostatic hyperplasia. Polish Sexology. 2010;8(2):55–59. [Google Scholar]
  • 6.Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical psychosocial correlates, results of Massachusetts Male Aging Study. J Urol. 1994;151:54–61. doi: 10.1016/s0022-5347(17)34871-1. [DOI] [PubMed] [Google Scholar]
  • 7.Montorsi F, Birganti A, Salona A, et al. Aging male and erectile dysfunction. BJU Int. 2003;5:28–32. doi: 10.1046/j.1464-410x.2003.04378.x. [DOI] [PubMed] [Google Scholar]
  • 8.Guest JF, Das Gupta R. Health-related quality of life in a UK-based population of men with erectile dysfunction. Pharmacoeconomics. 2002;20:109–117. doi: 10.2165/00019053-200220020-00004. [DOI] [PubMed] [Google Scholar]
  • 9.Li MK, Garcia L, Patron N, et al. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function. BJU Int. 2007;101:197–202. doi: 10.1111/j.1464-410X.2007.07320.x. [DOI] [PubMed] [Google Scholar]
  • 10.Giuliano HA, Leriche A, Jaudinot EO, de Gendre AS. Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both. Urology. 2004;64(6):1196–1201. doi: 10.1016/j.urology.2004.08.059. [DOI] [PubMed] [Google Scholar]
  • 11.Terai A, Ichioka K, Matsui Y, et al. Association of lower urinary tract symptoms with erectile dysfunction in Japanese men. Urology. 2004;64:132–136. doi: 10.1016/j.urology.2004.02.019. [DOI] [PubMed] [Google Scholar]
  • 12.Li MK, Garcia LA, Rosen R. Lower urinary tract symptoms and male sexual dysfunction in Asia: a survey of ageing men from five Asian countries. BJU Int. 2005;96:1339–1354. doi: 10.1111/j.1464-410X.2005.05831.x. [DOI] [PubMed] [Google Scholar]
  • 13.Ponholzer A, Madersbacher S. Lower urinary tract symptoms and erectile dysfunction links for diagnosis, management and treatment. Int J Impot Res. 2007;19:544–550. doi: 10.1038/sj.ijir.3901578. [DOI] [PubMed] [Google Scholar]
  • 14.McVary KT. Sexual dysfunction in men with lower urinary tract symptoms and benign prostatic hyperplasia: an emerging link. BJU Int. 2003;91:770–771. doi: 10.1046/j.1464-410x.2003.04252.x. [DOI] [PubMed] [Google Scholar]
  • 15.Hopps CV, Mulhall JP. Assessment of the impact of sildenafil citrate on lower urinary tract symptoms (LUTS) in men with erectile dysfunction (ED) J Urol. 2003;169(Suppl 4):375: A 1401. doi: 10.1111/j.1743-6109.2006.00259.x. [DOI] [PubMed] [Google Scholar]
  • 16.Brookes ST, Donovan JL, Peters TJ, et al. Sexual dysfunction in men after treatment for lower urinary tract symptoms: evidence from randomized controlled trial. BM6J. 2002;324:1059–1061. doi: 10.1136/bmj.324.7345.1059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Shepherd S. Aetiological factors in BPH. Sexual activity. In: Garraway M, editor. Epidemiology of prostate disease. Berlin Heidelberg: Springer-Verlag; 1995. pp. 114–115. [Google Scholar]
  • 18.Hamdy FC, Carretero P, Perrin P. The impact of age, drugs and disease on sexual activity in European men. In: Dimopolous CA, Di Silverio F, editors. BPH from molecular biology to patient relief. Monduzzi Ed. International Proceedings Division; 1996. [Google Scholar]
  • 19.Da Silva CF. BPH and quality of life. Place of sexuality. In: Dimopoulos CA, Di Silverio F, editors. BPH from molecular biology relief. Monduzzi Ed. International Proceeding Division; 1996. [Google Scholar]
  • 20.Kassabian VS. Sexual function in patients treated for benign prostatic hyperplasia. Lancet. 2003;4(9351):60–62. doi: 10.1016/S0140-6736(03)12164-2. [DOI] [PubMed] [Google Scholar]
  • 21.Platz EA, Kawachi I, Rimm EB, et al. Race, ethnicity and benign prostatic hyperplasia in the health professional follow-up study. J Urol. 2000;163:490–495. [PubMed] [Google Scholar]
  • 22.Wolters R, Wensing M, Van Wiel C, et al. Lower urinary tract symptoms: social influence is more important than symptoms seeking medical care. BJU Int. 2002;90:655–661. doi: 10.1046/j.1464-410x.2002.02996.x. [DOI] [PubMed] [Google Scholar]

Articles from Central European Journal of Urology are provided here courtesy of Polish Urological Association

RESOURCES